0001209191-23-043005.txt : 20230720 0001209191-23-043005.hdr.sgml : 20230720 20230720214603 ACCESSION NUMBER: 0001209191-23-043005 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230720 FILED AS OF DATE: 20230720 DATE AS OF CHANGE: 20230720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Affiliates Fund V, L.P. CENTRAL INDEX KEY: 0001589095 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41747 FILM NUMBER: 231100961 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Venture Capital V, L.P. CENTRAL INDEX KEY: 0001589097 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41747 FILM NUMBER: 231100963 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Ophthalmic Affiliates I, L.P. CENTRAL INDEX KEY: 0001589098 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41747 FILM NUMBER: 231100962 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Venture Capital V (Canada), LP CENTRAL INDEX KEY: 0001612235 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41747 FILM NUMBER: 231100958 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Ventures V GP-GP (Canada), Inc. CENTRAL INDEX KEY: 0001619297 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41747 FILM NUMBER: 231100960 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-2215 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Vantage II GP, L.P. CENTRAL INDEX KEY: 0001839790 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41747 FILM NUMBER: 231100956 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-801-8100 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Ventures V (Canada), L.P. CENTRAL INDEX KEY: 0001716490 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41747 FILM NUMBER: 231100959 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: (650) 843-5000 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Ventures V, LLC CENTRAL INDEX KEY: 0001619298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41747 FILM NUMBER: 231100964 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-2215 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Vantage II, L.P. CENTRAL INDEX KEY: 0001832235 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41747 FILM NUMBER: 231100955 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-801-8100 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Vantage II GP-GP, LLC CENTRAL INDEX KEY: 0001839789 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41747 FILM NUMBER: 231100957 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-801-8100 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 1650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Turnstone Biologics Corp. CENTRAL INDEX KEY: 0001764974 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 832909368 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 920 BROADWAY STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 347-897-5988 MAIL ADDRESS: STREET 1: 920 BROADWAY STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2023-07-20 0 0001764974 Turnstone Biologics Corp. TSBX 0001619298 Versant Ventures V, LLC ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104 0 0 1 0 0001589097 Versant Venture Capital V, L.P. ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104 0 0 1 0 0001589098 Versant Ophthalmic Affiliates I, L.P. ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104 0 0 1 0 0001589095 Versant Affiliates Fund V, L.P. ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104 0 0 1 0 0001619297 Versant Ventures V GP-GP (Canada), Inc. ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104 0 0 1 0 0001716490 Versant Ventures V (Canada), L.P. ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104 0 0 1 0 0001612235 Versant Venture Capital V (Canada), LP ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104 0 0 1 0 0001839789 Versant Vantage II GP-GP, LLC ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104 0 0 1 0 0001839790 Versant Vantage II GP, L.P. ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104 0 0 1 0 0001832235 Versant Vantage II, L.P. ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104 0 0 1 0 Series A Preferred Stock Common Stock 988832 I By Versant Venture Capital V, L.P. Series A Preferred Stock Common Stock 75255 I By Versant Venture Capital V (Canada) LP Series A Preferred Stock Common Stock 32971 I By Versant Ophthalmic Affiliates Fund I, L.P. Series A Preferred Stock Common Stock 29744 I By Versant Affiliates Fund V, L.P. Series B-1 Preferred Stock Common Stock 442055 I By Versant Venture Capital V, L.P. Series B-1 Preferred Stock Common Stock 33642 I By Versant Venture Capital V (Canada) LP Series B-1 Preferred Stock Common Stock 14739 I By Versant Ophthalmic Affiliates Fund I, L.P. Series B-1 Preferred Stock Common Stock 13297 I By Versant Affiliates Fund V, L.P. Series B-2 Preferred Stock Common Stock 957787 I By Versant Venture Capital V, L.P. Series B-2 Preferred Stock Common Stock 72892 I By Versant Venture Capital V (Canada) LP Series B-2 Preferred Stock Common Stock 31936 I By Versant Ophthalmic Affiliates Fund I, L.P. Series B-2 Preferred Stock Common Stock 28810 I By Versant Affiliates Fund V, L.P. Series C Preferred Stock Common Stock 140190 I By Versant Venture Capital V, L.P. Series C Preferred Stock Common Stock 10669 I By Versant Venture Capital V (Canada) LP Series C Preferred Stock Common Stock 4667 I By Versant Ophthalmic Affiliates Fund I, L.P. Series C Preferred Stock Common Stock 4216 I By Versant Affiliates Fund V, L.P. Series D Preferred Stock Common Stock 274990 I By Versant Vantage II, L.P. Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock will automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering and have no expiration date. Shares are held by Versant Venture Capital V, L.P. ("Versant V"). Versant Ventures V, LLC ("Versant V GP") is the sole general partner of Versant V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Versant V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Versant V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports. Shares are held by Versant Venture Capital V (Canada) LP ("Canada V"). Versant Ventures V (Canada), L.P. ("Canada V GP") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. ("Canada V GP-GP") is the sole general partner of Canada V GP. Jerel C. Davis is a director of Canada V GP-GP and may be deemed to share voting and dispositive power over the shares held by Canada V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports. Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. ("Ophthalmic"). Versant V GP is the sole general partner of Ophthalmic. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Ophthalmic. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports. Shares are held by Versant Affiliates Fund V, L.P. ("Affiliates V"). Versant V GP is the sole general partner of Affiliates V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Affiliates V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Affiliates, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports. Shares held by Versant Vantage II, L.P. ("Vantage II"). Versant Vantage II GP, L.P. ("Vantage II GP") is the sole general partner of Vantage II and Versant Vantage II GP-GP, LLC (Vantage II GP-GP") is the sole general partner of Vantage II GP. Jerel C. Davis is a managing director of Vantage II GP-GP and may be deemed to share voting and dispositive power over the shares held by Vantage II. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports. Versant Ventures V, LLC, By /s/ Max Eisenberg, Chief Operating Officer 2023-07-20 Versant Venture Capital V, L.P., By Versant Ventures V, LLC, its general partner, By /s/ Max Eisenberg, Chief Operating Officer 2023-07-20 Versant Ophthalmic Affiliates Fund I, L.P., By Versant Ventures V, LLC, its general partner, By /s/ Max Eisenberg, Chief Operating Officer 2023-07-20 Versant Affiliates Fund V, L.P., By Versant Ventures V, LLC, its general partner, By /s/ Max Eisenberg, Chief Operating Officer 2023-07-20 Versant Ventures V GP-GP (Canada), Inc., By /s/ Max Eisenberg, Chief Operating Officer 2023-07-20 Versant Ventures V (Canada), L.P., By Versant Ventures V GP-GP (Canada), Inc., its general partner, By /s/ Max Eisenberg, Chief Operating Officer 2023-07-20 Versant Venture Capital V (Canada), LP, By Versant Ventures V (Canada), L.P., its general partner, By Versant Ventures V GP-GP (Canada), Inc., its general partner, By /s/ Max Eisenberg, Chief Operating Officer 2023-07-20 Versant Vantage II GP-GP, LLC, By /s/ Max Eisenberg, Chief Operating Officer 2023-07-20 Versant Vantage II GP, L.P., By Versant Vantage II GP-GP, LLC, its general partner, By /s/ Max Eisenberg, Chief Operating Officer 2023-07-20 Versant Vantage II, L.P., By Versant Vantage II GP, L.P., its general partner, By Versant Vantage II GP-GP, LLC, its general partner, By /s/ Max Eisenberg, Chief Operating Officer 2023-07-20